Welcome to Cross-Canada Paediatric - Respiratory Residency Rounds


  1. WH. Sour skin, a bacterial rot of onion bulbs. Phytopath 1950;40:115-7.
  2. Ederer GM, Matsen JM. Colonization and infection with Pseudomonas cepacia. J Infect Dis 1972;125:612-8.
  3. Laraya-Cuasay LR, Lipstein M, Huang NN. Pseudomonas cepacia in the respiratory flora of patients with cystic fibrosis. Pediatr Res 1977;11:502.
  4. Isles A, Maclusky I, Corey M, et al. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr 1984;104:206-210.
  5. Thomassen MJ, Demko CA, Klinger JD, et al. Pseudomonas cepacia colonisation amongst patients with cystic fibrosis. A new opportunist. Am Rev Respir Dis 1985;131:791-6.
  6. Tablan OC, Martone WJ, Jarvis WR. The epidemiology of Pseudomonas cepacia in patients with cystic fibrosis. Eur J Epidemiol 1987;3:336-42.
  7. Tablan OC, Martone WJ, Deerkshuk CF, et al. Colonisation of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes. Chest 1987;91:527-32.
  8. Tablan OC, Chorba TL, Schidlow DV, et al. Pseudomonas cepacia colonisation in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr 1985;107:382-7.
  9. Thomassen MJ, Demko CA, Doershuk CF, et al. Pseudomonas cepacia: decrease in colonisation in patients with cystic fibrosis. Am Rev Respir Dis 1986;134:669-71.
  10. Millar-Jones L, Paull A, Saunders Z, et al. Transmission of Pseudomonas cepacia amongst cystic fibrosis patients. Lancet 1992;340:491.
  11. Pegues DA, Carson LA, Tablan OC, et al. Acquisition of Pseudomonas cepacia at summer camps for patients with cystic fibrosis. J Pediatr 1994;124:694-702.
  12. ] LiPuma JJ, Dasen SE, Nielson DW, et al. Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet 1990;336:1094-6.
  13. LiPuma JJ, Mortensen JE, Dasen SE, et al. Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment centres. J Pediatr 1988;113:859-862.
  14. Govan JRW, Brown PH, Maddison J, et al. Evidence of transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 1993;342:15-9.
  15. LiPuma JJ. Burkholderia cepacia complex: a contraindication to lung transplantation in cystic fibrosis? Transpl Infect Dis 2001;3:149-60.
  16. Speert DP, Henry D, Vandamme P, et al. Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada. Emerg Infect Dis 2002;8:181-7.
  17. Alexander BD, Petzold EW, Reller LB, et al. Survival after lung transplantation of cystic fibrosis patients infected with Burkholderia cepacia complex. Am J Transplant 2008;8:1025-30.
  18. Sun L, Jiang R-Z, Steinbach S, et al. The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nature Med 1995;1:661-6.
  19. Chaparro C, Maurer J, Gutierrez C, et al. Infection with Burkholderia cepacia in cystic fibrosis: outcome following lung transplantation. Am J Respir Crit Care Med 2001;163:43-8.
  20. Noyes BE, Kurland G, Orenstein DM, et al. Experience with pediatric lung transplantation. J Pediatr 1994;124:261-8.
  21. Egan JJ, McNeil K, Bookless B, et al. Post-transplantation survival of cystic fibrosis patients infected with Pseudomonas cepacia. Lancet 1994;344:552-3.
  22. Flume PA, Egan TM, Paradowski LJ, et al. Infectious complications of lung transplantation. Impact of cystic fibrosis. Am J Respir Crit Care Med 1994;149:1601-7.
  23. Kanj SS, Tapson V, Davis RD, et al. Infections in patients with cystic fibrosis following lung transplantation. Chest 1997;112:924-30.
  24. De Soyza A, McDowell A, Archer L, et al. Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis. Lancet 2001;358:1780-1.
  25. Boussaud V, Guillemain R, Grenet D, et al. Clinical outcome following lung transplantation in patients with cystic fibrosis colonised with Burkholderia cepacia complex: results from two French centres. Thorax 2008;63:732-7.

Next page / / References